Results 71 to 80 of about 549,379 (280)

Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials

Clinical Cancer Research, 2018
Purpose: Because of the uneven geographic distribution and small number of randomized trials available, the value of additional induction chemotherapy (IC) to concurrent chemoradiotherapy (CCRT) in nasopharyngeal carcinoma (NPC) remains controversial ...
Yupei Chen, L. Tang, Qi Yang, S. Poh, E. Hui, A. Chan, W. Ong, T. Tan, J. Wee, Wen-Fei Li, Lei Chen, B. Ma, M. Tong, S. Tan, S. Cheah, K. Fong, K. Sommat, Y. Soong, Ying Guo, A. Lin, Ying Sun, M. Hong, S. Cao, Ming-Yuan Chen, Jun Ma   +24 more
semanticscholar   +1 more source

Salvage esophagectomy for unresectable locally advanced esophageal squamous cell carcinoma: Significant or not?

Annals of Gastroenterological Surgery, EarlyView.
Abstract We reviewed the current status and perspectives on salvage esophagectomy for initially unresectable locally advanced esophageal squamous cell carcinoma (ESCC) in the era of minimally invasive surgery and immunotherapy. Although the standard treatment for these patients is definitive chemoradiotherapy (CRT), the complete response rate to CRT ...
Hiroshi Saeki, Makoto Sakai, Takayoshi Watanabe, Makoto Sohda, Ken Shirabe   +4 more
wiley   +1 more source

Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer

Cancer Cell International, 2018
Background To investigate the efficacy and safety of concurrent chemoradiotherapy with capecitabine or oxaliplatin in locally advanced (T3-4/N + M0) rectal cancer.
Wanghua Chen, Wenling Wang, Yuxin Li, Hongmin Dong, Gang Wang, Xiaokai Li   +5 more
doaj   +1 more source

Chemoradiotherapy for Inoperable Carotid Body Leiomyosarcoma: A Case Report and Review of Literature

Frontiers in Oncology, 2021
Vascular leiomyosarcoma is an extremely rare tumor and is associated with poor prognosis among leiomyosarcoma. Surgical resection remains the main treatment option.
Cheng-Sheng Liu, Jia-Ruey Tsai, Yi-Tzu Kao, Long-Sheng Lu, Long-Sheng Lu, Long-Sheng Lu, Yin-Ju Chen, Yin-Ju Chen, Yin-Ju Chen, Thierry Burnouf, Thierry Burnouf, Peng-Yuan Wang, Peng-Yuan Wang, Jeng-Fong Chiou, Jeng-Fong Chiou, Jeng-Fong Chiou, Lai-Lei Ting   +16 more
doaj   +1 more source

Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study

Annals of Oncology, 2018
Background Concurrent chemoradiotherapy (CCRT) is superior to radiotherapy alone for treating locoregionally advanced nasopharyngeal carcinoma (NPC).
R. Hong, C. Hsiao, L. Ting, J. Ko, Chun-Wei Wang, J. T. Chang, P. Lou, Hung-Ming Wang, M. Tsai, S. Lai, T. Liu   +10 more
semanticscholar   +1 more source

Brassinin from Brassica campestris L. inhibits colorectal cancer by inducing p62/NRF2/GPX4‐regulated ferroptosis

Animal Models and Experimental Medicine, EarlyView.
BSN suppresses the cell viability of colorectal cancer by inducing GPX4‐regulated ferroptosis. BSN may bind to NRF2 protein to inactivate the NRF2 signaling, inhibiting the expression of p62 and HO‐1. Abstract Background Indole phytoalexins, plant‐derived compounds present in cruciferous vegetables, have demonstrated anticancer properties.
Shi‐Yuan Wen, Rui‐Rui Gao, Yan‐Yan Chen, Yi‐Jie Wang, Xin‐Tong Wang, Hai‐Xin Liu   +5 more
wiley   +1 more source

A Randomized study on the Effects of Paclitaxel Liposme and Cisplatin Induction Chemotherapy Followed Concurrent Chemoradiotherapy and Sequential Radiotherapy on Locally Advanced Non-small Cell Lung Cancer Patients

Chinese Journal of Lung Cancer, 2011
Background and objective Sequential and concurrent chemoradiotherapy were widely studied in locally advanced non-small cell lung cancer (NSCLC), but the reports of induction chemotherapy followed concurrent chemoradiotherapy are rare so far.
Youyi DAI, Wuzhong JIANG, Jun YUAN, Rui WEI   +3 more
doaj  

Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.

Journal of Clinical Oncology, 2018
Purpose Both concurrent chemoradiotherapy (CT-RT) and cetuximab radiotherapy (cetux-RT) have been established as the standard of care for the treatment of locally advanced squamous cell carcinoma of the head and neck.
L. Geoffrois, L. Martin, D. de Raucourt, X. Sun, Y. Tao, P. Maingon, J. Buffet, Y. Pointreau, C. Sire, C. Tuchais, E. Babin, A. Coutte, F. Rolland, M. Kaminsky, M. Alfonsi, M. Lapeyre, M. Saliou, C. Lafond, E. Jadaud, B. Géry, A. Zawadi, J. Tourani, C. Khoury, A. Henry, A. Hasbini, F. Guichard, C. Borel, N. Meert, P. Guillet, marie-Helene Calais, P. Garaud, J. Bourhis   +31 more
semanticscholar   +1 more source

X‐ray controlled release strategy in cancer therapy

BMEMat, EarlyView.
A comprehensive review on the design principles and current strategies of X‐ray stimulated release systems in cancer therapy, focusing on the X‐ray responsive functional groups and materials as well as discussing the advantages and current challenges of X‐ray controlled release systems in cancer therapy.
Yiling Ruan, Hongxiang Huang, Huihui Liu, Jinglang Gong, Changjun Li, Xiaolian Sun   +5 more
wiley   +1 more source

Improved survival in patients with unresectable stage III EGFR‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors

Thoracic Cancer, 2022
Background Although epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) have been the standard treatment for advanced EGFR‐mutant adenocarcinoma, the effects of upfront EGFR‐TKI use in unresectable stage III EGFR‐mutant adenocarcinoma
Sheng‐Yuan Wang, Ching‐Han Lai, Chian‐Wei Chen, Szu‐Chun Yang, Chao‐Chun Chang, Chia‐Ying Lin, Yi‐Ting Yen, Yau‐Lin Tseng, Po‐Lan Su, Chien‐Chung Lin, Wu‐Chou Su   +10 more
doaj   +1 more source